Stemming from SEC Guidance Concerning Accounting Treatment of Warrants, Golden Arrow Merger Corp. Announces Receipt of Nasdaq...
June 04 2021 - 4:45PM
Golden Arrow Merger Corp. (the “Company”) today announced
that on May 28, 2021 it received a deficiency letter (the “Notice”)
from the Nasdaq Capital Market (“Nasdaq”) relating to the Company’s
failure to timely file its Quarterly Report on
Form 10-Q for the quarter ended March 31, 2021 (the
“Form 10-Q”) as required under Section 5250(c) of
the Nasdaq Rules and Regulations.
On April 12, 2021, the staff of the
Securities and Exchange Commission (“SEC”) issued “Staff Statement
on Accounting and Reporting Considerations for Warrants Issued by
Special Purpose Acquisition Companies (“SPACs”)” (the “Statement”),
which clarified guidance for all SPAC-related companies regarding
the accounting and reporting for their warrants. The immediacy of
the effective date of the new guidance set forth in the Statement
has resulted in a significant number
of SPACs re-evaluating the accounting treatment
for their warrants with their professional advisors, including
auditors and other advisors responsible for assisting SPACs in the
preparation of financial statements. This, in turn, has
resulted in the Company’s delay in preparing and finalizing its
financial statements as of and for the quarter ended March 31,
2021 and filing its Form 10-Q with the SEC by the
prescribed deadline. Since receiving the Notice, the Company has
filed its Form 10-Q with the SEC on June 4, 2021 and is in
compliance with all other Nasdaq continued listing standards.
About Golden Arrow Merger
Corp.
Golden Arrow Merger Corp. is a blank check company formed as a
Delaware corporation for the purpose of effecting a merger, capital
stock exchange, asset acquisition, stock purchase, reorganization
or similar business combination with one or more businesses. While
the Company may pursue an acquisition opportunity in any business,
industry, sector, or geography, it intends to initially focus its
search on identifying a prospective target business in the
healthcare or healthcare-related infrastructure industries in the
United States and other developed countries.
Forward Looking Statements
This press release contains statements that constitute
“forward-looking statements.” Forward-looking statements are
subject to numerous conditions, many of which are beyond the
control of the Company, including those set forth in the Risk
Factors section of the Company’s final prospectus filed with the
SEC on March 18, 2021, the Company’s Form 10-Q filed with the SEC
on June 4, 2021, and subsequent reports filed with the SEC. Copies
are available on the SEC’s website, www.sec.gov. The Company
undertakes no obligation to update these statements for revisions
or changes after the date of this release, except as required by
law.
Media Contact: Golden Arrow Merger Corp.
Valerie Toomey info@goldenarrowspac.com
Golden Arrow Merger (NASDAQ:GAMC)
Historical Stock Chart
From Sep 2024 to Oct 2024
Golden Arrow Merger (NASDAQ:GAMC)
Historical Stock Chart
From Oct 2023 to Oct 2024